Christopher Evans PhD, DSc is the John and Posy Krehbiel Professor ofOrthopedics at the Mayo Clinic, with the academic rank of Professor of Physical Medicine and Rehabilitation, Orthopedic Surgery and Molecular Medicine in the Mayo Clinic College of Medicine and Science. Dr. Evans earned BSc, PhD and DSc degrees in genetics, microbiology and biochemistry at the University of Wales, United Kingdom. He completed a postdoctoral fellowship in molecular biology at the Free University of Brussels, Belgium and earned a MA in the history and philosophy of
science at the University of Pittsburgh. He has an honorary MA from Harvard Medical School, where he is the Maurice Müller Professor of Orthopaedic Surgery Emeritus.

Dr. Evans uses his background in cell and molecular biology to study clinical problems involving bones and joints, with an emphasis on gene therapy. His research has two main areas of focus: arthritis and regenerative orthopedics. He and his colleagues conducted the first human clinical trial of gene therapy for arthritis and subsequently developed a gene therapy for osteoarthritis that recently completed a Phase I clinical trial at Mayo Clinic. Research into regenerative applications of gene therapy focuses on bone healing, cartilage repair and tendon healing; this work is at a preclinical stage.